A randomized open rabel study of the effects of aripiprazole in overweight and obstructive sleep apnea subjects with schizophrenia or schizoaffective disorder switched from other antipsychotic drugs.
Not Applicable
- Conditions
- Schizophrenia Schizoaffective Disorder Obstructive Sleep Apnea Syndrome
- Registration Number
- JPRN-UMIN000005355
- Lead Sponsor
- Biwako Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
Not provided
Exclusion Criteria
1.3% oxygen desaturation index evaluated with overnight pulseoxymetry in participants is less than 5 times per hour.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body Mass Index Apnea Hypopnea Index
- Secondary Outcome Measures
Name Time Method The Brief Assessment of Cognition in Schizophrenia;BACS Positive and Negative Syndrome Scale;PANSS Activity assesed by actipraph